New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central ...

Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute ...

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...

New research led by scientists in Ireland has uncovered how a fat-rich fluid found in the abdomen of ovarian cancer patients ...

Recent research conducted by scientists in Ireland has revealed the significant role of lipid-rich fluid in the abdomen, ...

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central ...

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

Led by Ludwig Princeton’s Lydia Lynch and reported in the current issue of Science Immunology, the study details how ascites fluid—produced in large quantities as ovarian cancer spreads from ...

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune ...

New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian cancer.

Eight patients with alcoholic cirrhosis and ascites were studied. In 4 patients, urine was collected from 8 a.m. to 12 noon, 12 noon to 3 p.m., 3 p.m. to 6 p.m. and 6 p.m. to 8 a.m. for two ...

New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...